Cargando…
Identification of hsa-miR-1275 as a Novel Biomarker Targeting MECP2 for Human Epilepsy of Unknown Etiology
Epilepsy affects around 70 million people worldwide, with a 65% rate of unknown etiology. This rate is known as epilepsy of unknown etiology (EUE). Dysregulation of microRNAs (miRNAs) is recognized to contribute to mental disorders, including epilepsy. However, miRNA dysregulation is poorly understo...
Autores principales: | Zhao, Ye, Lu, Congxia, Wang, Huiling, Lin, Qing, Cai, Liangliang, Meng, Fanrong, Tesfaye, Enque Biniam, Lai, Hsin-Chih, Tzeng, Chi-Meng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677659/ https://www.ncbi.nlm.nih.gov/pubmed/33251277 http://dx.doi.org/10.1016/j.omtm.2020.10.005 |
Ejemplares similares
-
Prevalence of Neural Autoantibodies in Epilepsy of Unknown Etiology: Systematic Review and Meta-Analysis
por: Cabezudo-García, Pablo, et al.
Publicado: (2021) -
High frequency of cerebrospinal fluid autoantibodies in patients with seizures or epilepsies of unknown etiology
por: Schulz, Paulina, et al.
Publicado: (2023) -
Correction to Lancet Respir Med 2021; 9: 1275–87
Publicado: (2022) -
β-elemene alleviates airway stenosis via the ILK/Akt pathway modulated by MIR143HG sponging miR-1275
por: Zhang, Guoying, et al.
Publicado: (2021) -
Genetic Variants Identified from Epilepsy of Unknown Etiology in Chinese Children by Targeted Exome Sequencing
por: Wang, Yimin, et al.
Publicado: (2017)